US FDA Drug Center ‘Snapshots’ Show Progress, But Are They Measuring The Right Thing?

 
• By Michael McCaughan
diversity hands
Califf wants larger trials to better measure treatment effects in subgroups of interest. • Source: Shutterstock

More from Clinical Trials

More from R&D